➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Baxter
Mallinckrodt
Medtronic
Boehringer Ingelheim
Moodys

Last Updated: June 25, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for GTS-21


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug GTS-21?

GTS-21 is an investigational drug.

There have been 8 clinical trials for GTS-21. The most recent clinical trial was a Phase 2 trial, which was initiated on June 16th 2018.

The most common disease conditions in clinical trials are Tourette Syndrome, Schizophrenia, and Syndrome. The leading clinical trial sponsors are CoMentis, University of Colorado, Denver, and National Institute of Mental Health (NIMH).

Recent Clinical Trials for GTS-21
TitleSponsorPhase
Selective Microbiota Transplantation for Tourette's SyndromeFaming ZhangPhase 1/Phase 2
Evaluating the Efficacy and Safety of Yi-Gan San in Children and Adolescents With Tourette's DisorderChina Medical University HospitalPhase 2
Effects of GTS-21 on Smoking Behavior and Neurocognitive FunctionsUniversity of FloridaPhase 2

See all GTS-21 clinical trials

Clinical Trial Summary for GTS-21

Top disease conditions for GTS-21
Top clinical trial sponsors for GTS-21

See all GTS-21 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Johnson and Johnson
Baxter
Mallinckrodt
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.